Smoking cessation advice for people with serious mental illness

Cochrane Database of Systematic Reviews

Volumn 2016, Issue 1, 2016, Pages

  Khanna, Priya ^a   Clifton, Andrew V ^b   Banks, David ^c   Tosh, Graeme E ^d  

^a TYNE AND WEAR NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF HUDDERSFIELD   (United Kingdom)

^c QUEEN MARGARET UNIVERSITY   (United Kingdom)

^d ROTHERHAM DONCASTER AND SOUTH HUMBER NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AWARENESS; DISEASE SEVERITY; HEALTH CARE PERSONNEL; HUMAN; MENTAL DISEASE; MENTAL PATIENT; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; RISK FACTOR; SMOKING CESSATION; SOCIOECONOMICS; SYSTEMATIC REVIEW; COUNSELING;

COUNSELING; HUMANS; MENTAL DISORDERS; SMOKING CESSATION;

EID: 84969933381     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009704.pub2     Document Type: Review

References (58)

1. Baker A, Richmond R, Haile M, Lewin TJ, Carr VJ, Taylor RL, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. The American Journal of Psychiatry 2006;163(11):1934-42. [PUBMED: 17074945]
2. Brown RA, Strong DR, Abrantes AM, Myers MG, Ramsey SE, Kahler CW. Effects on substance use outcomes in adolescents receiving motivational interviewing for smoking cessation during psychiatric hospitalization. Addictive Behaviors 2009;34(10):887-91. [PUBMED: 19342179]
3. Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin 1997;23(2):247-54. [PUBMED: 9165635]
4. NCT00500695. Enhancing Motivation To Quit Smoking In Smokers With Serious Mental Illness. https://clinicaltrials.gov/ct2/show/NCT00500695 (accessed April 2015). [NCT00500695]
5. Altman DG, Bland JM. Detecting skewness from summary information. BMJ 1996;313(7066):1200. [PUBMED: 8916759]
6. American Medical Association. Family Medical Guide. Wiley, 2004. [978-0471269113]
7. Banham L, Gilbody S. Smoking cessation in severe mental illness: what works?. Addiction 2010;105(7):1176-89. [PUBMED: 20491721]
8. Bland JM. Statistics notes. Trials randomised in clusters. BMJ 1997;315(7108):600. [PUBMED: 9302962]
9. Boissel JP, Cucherat M, Li W, Chatellier G, Gueyffier F, Buyse M, et al. The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use [Apercu sur la problematique des indices d'efficacite therapeutique, 3: comparaison des indices et utilisation. Groupe d'etude des indices d'efficacite]. Thérapie 1999;54(4):405-11. [PUBMED: 10667106]
10. Cournos F, McKinnon K, Sullivan G. Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus. Journal of Clinical Psychiatry 2005;66 Suppl 6:27-33. [PUBMED: 16107181]
11. Deeks J. Issues in the selection for meta-analyses of binary data. Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28; Cape Town. Cape Town: The Cochrane Collaboration, 2000.
12. Divine GW, Brown JT, Frazier LM. The unit of analysis error in studies about physicians' patient care behavior. Journal of General Internal Medicine 1992;7(6):623-9. [PUBMED: 1453246]
13. Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A. The association of medical comorbidity in schizophrenia with poor physical and mental health. Journal of Nervous and Mental Disease 1999;187(8):496-502. [PUBMED: 10463067]
14. Docherty B. Care in the community. Fire Prevention 1999;317:26-7.
15. Department of Health. Summary of Intelligence on Tobacco. Department of Health. 2004. http://www.erpho.org.uk/Download/Public/11077/1/WP%20Summary%20doc.pdf (accessed 1st March 2011):1-4.
16. Donner A, Klar N. Issues in the meta-analysis of cluster randomized trials. Statistics in Medicine 2002;21(19):2971-80. [PUBMED: 12325113]
17. Egger M, Davey-Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315(7109):629-34. [PUBMED: 9310563]
18. Elbourne D, Altman DG, Higgins JPT, Curtin F, Worthington HV, Vail A. Meta-analyses involving cross-over trials: Methodological issues. International Journal of Epidemiology 2002;31(1):140-9. [PUBMED: 11914310]
19. Ford J. The NHS is facing a deepening financial crisis. BMJ (Clinical research ed.) 2013;347:f4422. [PUBMED: 23843501]
20. Greenlund KJ, Giles WH, Keenan NL, Croft JB, Mensah GA. Physician advice, patient actions, and health-related quality of life in secondary prevention of stroke through diet and exercise. Stroke 2002;33(2):565-70. [PUBMED: 11823671]
21. Gulliford MC, Ukoumunne OC, Chinn S. Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994. American Journal of Epidemiology 1999;149(9):876-83. [PUBMED: 10221325]
22. Health Development Agency. Smoking and patients with mental health problems. 2004. http://www.nice.org.uk/proxy/?sourceUrl=http%3A%2F%2Fwww.nice.org.uk%2Fnicemedia%2Fdocuments%2Fsmoking_mentalhealth.pdf (accessed 1st March 2011):1-16.
23. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60. [PUBMED: 12958120]
24. Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
25. Kay SR, Opler LA, Fiszbein A. Positive and Negative Syndrome Scale (PANSS) Manual. North Tonawanda, New York: Multi-Health Systems, 1986.
26. Khokhar WA, Clifton A, Jones H, Tosh G. Oral health advice for people with serious mental illness. Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD008802.pub2]
27. Kreuter MW, Chheda SG, Bull FC. How does physician advice influence patient behavior? Evidence for a priming effect. Archives of Family Medicine 2000;9(5):426-33. [PUBMED: 10810947]
28. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel R. Clinical implications of Brief Psychiatric Rating Scale scores. British Journal of Psychiatry 2005;187:366-71. [PUBMED: 16199797]
29. Leucht S, Kane JM, Kissling W, Hamann J, Etschel E, Engel RR. What does the PANSS mean?. Schizophrenia Research 2005;79(2-3):231-8. [PUBMED: 15982856]
30. Leucht S, Engel RR, Bäuml J, Davis JM. Is the superior efficacy of new generation antipsychotics an artifact of LOCF?. Schizophrenia Bulletin 2007;33(1):183-91. [PUBMED: 16905632]
31. Marshall M, Lockwood A, Bradley C, Adams CE, Joy C, Fenton M. Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia. British Journal of Psychiatry 2000;176:249-52. [PUBMED: 10755072]
32. McCreadie RG, Kelly C. Patients with schizophrenia who smoke. Private disaster, public resource. British Journal of Psychiatry 2000;176:109. [PUBMED: 10755044]
33. McDonald C. Cigarette smoking in patients with schizophrenia. British Journal of Psychiatry 2000;176:596-7. [PUBMED: 10974973]
34. Meltzer H, Gill B, Petticrew M. Economic activity and social functioning of residents with psychiatric disorders. OPCS Surveys of Psychiatric Morbidity in Great Britain, Report 6. London: HMSO, 1996.
35. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Canadian Journal of Psychiatry 1991;36(4):239-45. [PUBMED: 1868416]
36. NHS Smokesfree. NHS Stop Smoking Services. Service and monitoring guidance 2010/11. http://webarchive.nationalarchives.gov.uk/20130107105354/http:/www.dh.gov.uk/prod_consum_dh/groups/dh_digitalassets/dh/en/ps/sta/perf/documents/digitalasset/dh_109889.pdf (accessed 1st March 2011).
37. National Institute for Health and Clinical Excellence. Brief interventions and referral for smoking cessation in primary care and other settings. March 2006. https://www.nice.org.uk/guidance/ph1/chapter/recommendations (accessed 1st March 2011).
38. National Institute for Health and Clinical Excellence. Psychosis with coexisting substance misuse. Assessment and management in adults and young people. NICE Clinical Guidelines, No. 120. March 2011. http://www.ncbi.nlm.nih.gov/books/NBK109783/pdf/Bookshelf_NBK109783.pdf (accessed 1st March 2011).
39. National Institute of Mental Health. Towards a Model for a Comprehensive Community-Based Mental Health System. Washington, DC: National Institute of Mental Health, 1987.
40. Overall JE, Gorham DR. The brief psychiatric rating scale. Psychological Reports 1962;10(3):799-812.
41. Peto R, Lopez AD, Boreham J, Thun M. Mortality From Smoking in Developed Countries 1950-2000. 2nd Edition. Oxford: Oxford University Press, 2006.
42. Phelan M, Stradins L, Morrison S. Physical health of people with severe mental illness. BMJ 2001;322(7284):443-4. [PUBMED: 11222406]
43. Robson D, Gray R. Serious mental illness and physical health problems: a discussion paper. International Journal of Nursing Studies 2007;44(3):457-66. [PUBMED: 17007859]
44. Ruggeri M, Leese M, Thornicroft G, Bisoffi G, Tansella M. Definition and prevalence of severe and persistent mental illness. British Journal of Psychiatry 2000;177:149-55. [PUBMED: 11026955]
45. Russell MA, Wilson C, Taylor C, Baker CD. Effect of general practitioners' advice against smoking. British Medical Journal 1979;2(6184):231-5. [PUBMED: 476401]
46. Schinnar AP, Rothbard AB, Kanter R, Jung YS. An empirical literature review of definitions of severe and persistent mental illness. American Journal of Psychiatry 1990;147(12):1602-8. [PUBMED: 2244636]
47. Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, et al. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions. Chichester: The Cochrane Collaboration, 2008:359-83.
48. Stott NC, Pill RM. 'Advise yes, dictate no'. Patients' views on health promotion in the consultation. Family Practice 1990;7(2):125-31. [PUBMED: 2369980]
49. Sutherland G. Smoking: can we really make a difference?. Heart 2003;89 Suppl 2:ii25-7; discussion ii35-7. [PUBMED: 12695432]
50. Tosh G, Clifton AV, Xia J, White MM. Physical health care monitoring for people with serious mental illness. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD008298.pub3]
51. Tosh G, Clifton AV, Xia J, White MM. General physical health advice for people with serious mental illness. Cochrane Database of Systematic Reviews 2014, Issue 3. [DOI: 10.1002/14651858.CD008567.pub3]
52. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD007253.pub3]
53. Ukoumunne OC, Gulliford MC, Chinn S, Sterne JAC, Burney PGJ. Methods for evaluating area-wide and organisation-based intervention in health and health care: a systematic review. Health Technology Assessment 1999;3(5):iii-92. [PUBMED: 10982317]
54. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2011: Warning about the dangers of tobacco. http://apps.who.int/iris/bitstream/10665/44616/1/9789240687813_eng.pdf (accessed 1st March 2011).
55. Wright N, Akhtar A, Tosh G, Clifton A. HIV prevention advice for people with serious mental illness. Cochrane Database of Systematic Reviews 2014, Issue 12. [DOI: 10.1002/14651858.CD009639.pub2]
56. Xia J, Adams CE, Bhagat N, Bhagat V, Bhoopathi P, El-Sayeh H, et al. Loss to outcomes stakeholder survey: the LOSS study. Psychiatric Bulletin 2009;33(7):254-7.
57. Zimmerman M. Diagnosing personality disorders. A review of issues and research methods. Archives of General Psychiatry 1994;51(3):225-45. [PUBMED: 8122959]
58. Khanna P, Clifton A, Banks D, Tosh G. Smoking cessation advice for people with serious mental illness. Cochrane Database of Systematic Reviews 2012, Issue 3. [DOI: 10.1002/14651858.CD009704]